Symmetric
  • TRAINING COURSES
  • IN-HOUSE TRAINING
  • CLIENTS
  • TRAINERS
  • BLOG
  • ABOUT US
  • CONTACT

Join Symmetric Newsletter

Sign up today so you don't miss any special offers, new events and pharma breaking news.

TOP 3 Pharma & Biotech Worldwide News Once a Month

Interviews With Industry Professionals Once Every Three Months

Regular Event Calendar & Special Offers Once Every Six Months

Symmetric s.r.o.

Mliekarenska 7

82109 Bratislava

Slovak Republic

ID: 47 068 124

VAT No: SK2023741973

Office: +421 948 262 346

LinkedIn

Booking & Support

Phone (EU):+421 948 262 346 (9:00 - 17:00 CET)

Phone (US):+1 857 392 2714 (9:00 - 16:00 ET)

Email:info@symmetric.events

A real member of our team answers our chat

Terms & ConditionsPrivacy PolicyChange Your Cookie Consent

© 2026 Symmetric s.r.o.

Orphan Drugs Clinical Trials
Clinical Trials
Pharma & Biotech

Orphan Drugs Clinical Trials

Date to be announced

Contact us for more info
Price available after dates are announced

TRAINING TIMES

  • TBDVienna
  • TBDLondon
  • TBDNew York
  • TBDLos Angeles
Online Training



LEARNING OBJECTIVES

Learning Objective

EMA and FDA expectations for Orphan Drugs clinical studies

EMA and FDA expectations for Orphan Drugs clinical studies

Learning Objective

The Importance of avoiding Bias and Regression to the Mean

The Importance of avoiding Bias and Regression to the Mean

Learning Objective

Working with Evidence Based Medicine and Clinical trials

Working with Evidence Based Medicine and Clinical trials

Learning Objective

How to design a study and which methodology to use?

How to design a study and which methodology to use?

Learning Objective

Practical implementation of regulatory pathways

Practical implementation of regulatory pathways

Learning Objective

Where do we need randomised trials?

Where do we need randomised trials?



KEY TOPICS

Orphan Drugs EU and US regulatory guidance
Legal basis for approvals (Regulatory pathways) & Working Groups
Trial concept, design and conclusions
The Importance of Precision and Confidence Intervals
Study designs and methodology considerations
What constitutes convincing evidence?

TRAINER

Dr. Simon Day

Dr. Simon Day

Clinical Trials Consulting & Training,

Simon has spent 30 years working in clinical trials, mostly in the pharmaceutical industry but also including five years at the UK and European regulatory agencies. He now works as a statistical and regulatory consultant to pharmaceutical and biotechnology companies around the world. He specialises in training and consulting on drug development programmes, scientific advice/end of Phase II meetings and preparations for oral explanations and advisory committees. He is particularly well known for his work in the area of developing treatments for rare diseases. Simon has served on a variety of data monitoring committees both for industry-sponsored and government-sponsored trials. He is chairman of the External Advisory Panel for the Department of Statistics at Oxford University and an Associate on the faculty at Johns Hopkins University in Baltimore. He formerly served as vice-Chairman of the West London Research Ethics Committee. He has given numerous lectures and courses on statistics and clinical trials all around the world, including courses at the FDA on the development and regulatory assessment of orphan drugs.

Learn More →